» Articles » PMID: 33119183

COVID-19, HIV and Key Populations: Cross-cutting Issues and the Need for Population-specific Responses

Overview
Journal J Int AIDS Soc
Date 2020 Oct 29
PMID 33119183
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Key populations at elevated risk to contract or transmit HIV may also be at higher risk of COVID-19 complications and adverse outcomes associated with public health prevention measures. However, the conditions faced by specific populations vary according to social, structural and environmental factors, including stigma and discrimination, criminalization, social and economic safety nets and the local epidemiology of HIV and COVID-19, which determine risk of exposure and vulnerability to adverse health outcomes, as well as the ability to comply with measures such as physical distancing. This commentary identifies common vulnerabilities and cross-cutting themes in terms of the impacts of COVID-19 on key populations before addressing issues and concerns specific to particular populations.

Discussion: Cross-cutting themes include direct impacts such as disrupted access to essential medicines, commodities and services such as anti-retroviral treatment, HIV pre-exposure prophylaxis, opioid agonist treatment, viral load monitoring, HIV and sexually transmitted infections testing, condoms and syringes. Indirect impacts include significant collateral damage arising from prevention measures which restrict human rights, increase or impose criminal penalties, and expand police powers to target vulnerable and criminalized populations. Significant heterogeneity in the COVID-19 pandemic, the underlying HIV epidemic and the ability of key populations to protect themselves means that people who inject drugs and sex workers face particular challenges, including indirect impacts as a result of police targeting, loss of income and sometimes both. Geographical variations mean that transgender people and men who have sex with men in regions like Africa and the middle east remain criminalized, as well as stigmatized and discriminated against, increasing their vulnerability to adverse outcomes in relation to COVID-19.

Conclusions: Disruptions to both licit and illicit supply chains, loss of income and livelihoods and changes in behaviour as a result of lockdowns and physical distancing have the potential to exacerbate the impacts of the COVID-19 pandemic on key populations. While these impacts will vary significantly, human-rights approaches to COVID-19 emergency laws and public health prevention measures that are population-specific and sensitive, will be key to reducing adverse health outcomes and ensuring that no one is left behind.

Citing Articles

Impact of COVID-19 on key populations and people living with HIV: recommendations and sociopolitical responses from the EPIC community research program in Latin America.

Stuardo Avila V, Apffel Font O, Leon Caceres A, Radusky P, Aristegui I, Mendoza H BMC Public Health. 2025; 25(1):971.

PMID: 40069811 PMC: 11898992. DOI: 10.1186/s12889-025-22017-7.


Use of a media campaign to improve access to contraception in Nigeria amid the COVID-19 pandemic: a cross-sectional survey.

Adeoye O, Odeh R, Nwala A, Edet F, Raji M, Ahmadu H BMJ Public Health. 2025; 1(1):e000192.

PMID: 40017871 PMC: 11812712. DOI: 10.1136/bmjph-2023-000192.


Disproportionate, differential and targeted treatment: people who use drugs' experiences of policing during the COVID-19 pandemic.

Walker S, Rathnayake K, Dietze P, Higgs P, Ward B, Hellard M Health Justice. 2025; 13(1):6.

PMID: 39847147 PMC: 11756195. DOI: 10.1186/s40352-024-00314-4.


Impact of the COVID-19 pandemic on sexually transmitted infection testing and diagnosis in Lebanon: A retrospective chart review.

Sunji N, Boufadel P, Fakih I, Ahmad J, Choufani M, Habib N Heliyon. 2024; 10(20):e39191.

PMID: 39640771 PMC: 11620255. DOI: 10.1016/j.heliyon.2024.e39191.


Navigating the COVID-19 Risk Environment, Overdose Prevention, and Self Care Practices of People Who Use Illicit Opioids in New York City.

Bennett A, McCollum Jr D, Elliott L Subst Use Misuse. 2024; 60(4):504-514.

PMID: 39623307 PMC: 11825269. DOI: 10.1080/10826084.2024.2434681.


References
1.
Shannon K, Crago A, Baral S, Bekker L, Kerrigan D, Decker M . The global response and unmet actions for HIV and sex workers. Lancet. 2018; 392(10148):698-710. PMC: 6384122. DOI: 10.1016/S0140-6736(18)31439-9. View

2.
Puras D, de Mesquita J, Cabal L, Maleche A, Meier B . The right to health must guide responses to COVID-19. Lancet. 2020; 395(10241):1888-1890. PMC: 7259895. DOI: 10.1016/S0140-6736(20)31255-1. View

3.
Poteat T, Scheim A, Xavier J, Reisner S, Baral S . Global Epidemiology of HIV Infection and Related Syndemics Affecting Transgender People. J Acquir Immune Defic Syndr. 2016; 72 Suppl 3:S210-9. PMC: 4969059. DOI: 10.1097/QAI.0000000000001087. View

4.
Wallace M, Hagan L, Curran K, Williams S, Handanagic S, Bjork A . COVID-19 in Correctional and Detention Facilities - United States, February-April 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(19):587-590. DOI: 10.15585/mmwr.mm6919e1. View

5.
Dunlop A, Lokuge B, Masters D, Sequeira M, Saul P, Dunlop G . Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduct J. 2020; 17(1):26. PMC: 7201394. DOI: 10.1186/s12954-020-00370-7. View